|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/21 | |
| A61K 9/16 | |||
| A61K 9/00 | |||
| A61K 47/18 |
| (11) | Patento numeris | 1755650 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05753131.1 |
| Europos patento paraiškos padavimo data | 2005-05-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-02-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2008-07-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/017914 |
| Data | 2005-05-23 |
| (87) | Numeris | WO 2005/115333 |
| Data | 2005-12-08 |
| (30) | Numeris | Data | Šalis |
| 574662 P | 2004-05-25 | US | |
| 650226 P | 2005-02-03 | US |
| (72) |
JUNNARKAR, Gunjan, US
DESJARDIN, Michael A., US
LIU, Kui, US
LI, Zengji, US
|
| (73) |
Intarcia Therapeutics, Inc.,
24650 Industrial Blvd., Emeryville CA 94545,
US
|
| (54) | A BIOMOLECULE-CONTAINING SUSPENSION FORMULATION OF INCREASED STABILITY DELIVERABLE VIA AN IMPLANTABLE DELIVERY DEVICE |
| A BIOMOLECULE-CONTAINING SUSPENSION FORMULATION OF INCREASED STABILITY DELIVERABLE VIA AN IMPLANTABLE DELIVERY DEVICE |